Laddar...
Immunoglobulin G2 Antibody as a Potential Target for COVID-19 Vaccine
The global threat of COVID-19 is continued with no commercially available vaccine or drug yet. While the application of convalescent therapy is usually beneficial, for critically ill patients, the detrimental effect associated with some antibodies is also reported. The immunoglobulin G (IgG) antibod...
Sparad:
| I publikationen: | Immunotargets Ther |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7532904/ https://ncbi.nlm.nih.gov/pubmed/33062618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S274746 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|